Back

The impact of different ages of onset on cardiopulmonary function in Chinese patients with systemic lupus erythematosus

27 August 2023 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Autoimmune disease and heart disease: clinical presentation and outcomes Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Mi ZHOU

Sichuan provincial people's hospital affiliate Wenjiang hospital, Chengdu (China)

7 More presentations in this session

Presentation thumbnail
Cardiac involvement in Behcet's syndrome: a case series of 32 patients
Doctor S. Chadli (Rabat, MA)
Abstract Slides Video
Presentation thumbnail
Association of proteomic signatures and immunophenotyping profiles with subclinical cardiovascular disease characterised by multimodal imaging in South African systemic lupus erythematosus patients
Doctor T. Bana (Cape Town, ZA)
Abstract Slides Video
Presentation thumbnail
Sarcoidosis is associated with a higher long-term risk of ischaemic heart disease, venous thromboembolism, and ischaemic stroke: a nationwide study
Doctor A. Yafasova (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Prognostic significance of pulmonary hypertension in patients with connective tissue disorders: review and meta-analysis
Doctor M. Gegenava (Tbilisi, GE)
Abstract Slides Video
Presentation thumbnail
Gout is associated with increased cardiovascular risk: results from analysis of the CPRD dataset
Doctor L. Ferguson (Glasgow, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Autoimmune disease and heart disease: clinical presentation and outcomes

The Event

Event poster

ESC Congress 2023

27 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular risk management in systemic autoimmune disorders
thumbnail
Congress Presentation
A cardiac conundrum - when a storm brews another
thumbnail
Congress Presentation
Cardiac abnormalities and the presence of modifiable cardiovascular risk factors in patients with systemic lupus erythematosus

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources